Moreover, detection rates of breast cancer using a combination of two conventional tumor markers (CA15-3/CEA, CA15-3/NCC-ST-439, or CEA/NCC-ST-439) with MK was significantly higher than those using combination of three conventional tumor markers. This evidence concerns the gene CEACAM5 and breast cancer.